ESR2 and cancer: This is the first report of a stimulation able to modulate the receptor in proliferating cells and the first study indicating that ERβ is sensitive to temperature variation; the investigation of the molecular differences between primary keratinocytes and HaCaT cells, which are not able to modulate ERβ, could help to understand and possibly overcome the defective ERβ expression in cancer cells.